103631-8

Natalizumab [Mass/volume] in Serum by Immunoassay

Active

Part Description

LP64671-8 Natalizumab
Natalizumab is a humanized monoclonal antibody against the cellular adhesion molecule α4-integrin. Natalizumab is used in the treatment of multiple sclerosis and Crohn's disease. The drug is believed to work by reducing the ability of inflammatory immune cells to attach to and pass through the cell layers lining the intestines and blood-brain barrier. Natalizumab has proven effective in treating the symptoms of both diseases, preventing relapse, vision loss, cognitive decline and significantly improving quality of life in people with multiple sclerosis, as well as increasing rates of remission and preventing relapse in Crohn's disease. Copyright Text is available under the Creative Commons Attribution/Share-Alike License. See http://creativecommons.org/licenses/by-sa/3.0/ for details. Source: Wikipedia, Wikipedia

LOINC Names Get Info

Fully-Specified Name: Natalizumab:MCnc:Pt:Ser:Ord:IA
Long Common Name: Natalizumab [Mass/volume] in Serum by Immunoassay
Short Name: Natalizumab Ser Ql IA
Display Name: Natalizumab IA Ql (S)
Consumer Name Alpha Get Info: Natalizumab, Blood

Part Model Get Info

Component
Natalizumab
LP64671-8
- Analyte
  Natalizumab
  LP64671-8
  - Component Numerator
    Natalizumab
    LP64671-8
    - Component Numerator Core
      Natalizumab
      LP64671-8
    - Component Numerator Core Suffix
      NULL
  - Component Denominator
    NULL
    - Component Denominator Core
      NULL
    - Component Denominator Core Suffix
      NULL
- Challenge
  NULL
- Adjustment
  NULL
- Count
  NULL
Property
MCnc
LP6827-2
Time
Pt
LP6960-1
- Time Core
  Pt
  LP6960-1
- Time Modifier
  NULL
System
Ser
LP7567-3
- System Core
  Ser
  LP7567-3
- Super System
  NULL
Scale
Ord
LP7751-3
Method
IA
LP217197-5

Basic Attributes

Class: DRUG/TOX
Type: Laboratory
First Released: Version 2.79
Last Updated: Version 2.79 (ADD)
Order vs. Observation: Both

Language Variants Get Info

Tag	Language	Translation
el-GR	Greek (Greece)	Ναταλιζουμάμπη:MCnc:Pt:Ορός:Ord:IA Synonyms: DRUG/TOX IA MCnc Ord Pt Ναταλιζουμάμπη Ορός
es-ES	Spanish (Spain)	Natilizumab:Concentración de masa:Punto temporal:Suero:Ord:IA
et-EE	Estonian (Estonia)	Natalisumaab:MCnc:Pt:S:Ord:IA Synonyms: Järgarvuline Juhuslik Seerum
fr-BE	French (Belgium)	Natalizumab:Concentration de masse:Temps ponctuel:Sérum:Ordinal:IA
fr-CA	French (Canada)	Natalizumab:Concentration de masse:Temps ponctuel:Sérum:Ordinal:IA
fr-FR	French (France)	Natalizumab:Masse/Volume:Ponctuel:Sérum:Qualitatif:Immunoanalyse
it-IT	Italian (Italy)	Natalizumab:MCnc:Pt:Siero:Ord:IA Synonyms: Concentrazione di Massa Immunoassay Livelli farmacologici e tossicologia Punto nel tempo (episodio) Siero
nl-NL	Dutch (Netherlands)	natalizumab:massa/volume:moment:serum:ordinaal:immunoassay Synonyms: IA
pl-PL	Polish (Poland)	Natalizumab:stężenie masowe:punkt w czasie:surowica:uporządkowany:metoda immunologiczna
ru-RU	Russian (Russian Federation)	Натализумаб:МассКонц:ТчкВрм:Сыв:Пор:IA Synonyms: Массовая концентрация Порядковый Сыворотка Точка во времени;Момент
tr-TR	Turkish (Turkey)	Natalizumab:KütlKons:Zmlı:Ser:Srl:İA Synonyms: İmmünölçüm, immünoassay
zh-CN	Chinese (China)	那他珠单抗:质量浓度:时间点:血清:序数型:免疫测定法 Synonyms: Natalizumab;Natalizumab 单抗;Tysabri;那他株单抗;那他珠单克隆抗体依次型;分类顺序型;定性的;序数型（或称等级型）;性质上的;有序型;有序性分类应答;有序性分类结果;秩次型;等级型;筛查;顺序型免疫测定;免疫分析法;免疫检定法;免疫检定;免疫试验;酶免疫测定法;酶免疫测定;酶免疫分析法;酶免疫检定法;酶免疫检定;酶免疫试验时刻;随机;随意;瞬间毒品毒品类水平;浓度;质量浓度(单位体积) 药品类药物药物/毒理学;药物/毒理学试验;药物毒理学试验;药物毒理学试验类药物类

Example Units

Unit	Source
ug/mL	Example UCUM Units

LOINC Terminology Service (API) using HL7^® FHIR^® Get Info

CodeSystem lookup: https://fhir.loinc.org/CodeSystem/$lookup?system=http://loinc.org&code=103631-8

LOINC Copyright

Copyright © Regenstrief Institute, Inc. All Rights Reserved. To the extent included herein, the LOINC table and LOINC codes are copyright © Regenstrief Institute, Inc. and the Logical Observation Identifiers Names and Codes (LOINC) Committee. See https://loinc.org/license for the full LOINC copyright and license.